Galectin Therapeutics Inc. (GALT) is Trading Lower on Unusual Volume for February 03

Equities Staff |

Galectin Therapeutics Inc. (GALT) experienced unusually high volume on Feb. 03, as the stock lost 3.97% to a closing price of $1.21. The stock saw 188,349 shares trade hands over the course of the day on 901 trades. Given that the stock’s average daily volume over the last month has been 119,145 shares a day, this represents a pretty substantial spike over the norm.

Galectin Therapeutics Inc. has a P/B ratio of 2.37. The stock has traded between $4.40 and $1.22 over the last 52-weeks, its 50-day SMA is now $1.69, and its 200-day SMA $2.39.

Galectin Therapeutics Inc is a clinical stage biopharmaceutical company. The Company is engaged in drug research and development to create new therapies for fibrotic disease and cancer.

Headquartered in Norcross, GA, Galectin Therapeutics Inc. has 7 employees and is currently under the leadership of CEO Peter G. Traber.

For a complete fundamental analysis analysis of Galectin Therapeutics Inc., check out Equities.com’s Stock Valuation Analysis report for GALT. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

THE IMPORTANCE OF THE RUSSELL 3000

The Russell 3000 is not well known outside the world of finance, but it’s one of the strongest indices out there for getting a broad sense of the stock market. Unlike the better-known Dow Jones Industrial Average or S&P 500, membership on the Russell 3000 isn’t selected by committee. It’s simply the 3,000 most valuable companies in the country.

With 3,000 stocks making up the index, it gives a broad look at the markets, including the small-and mid-cap companies that aren’t on the Dow or the S&P 500. And with a rules-based system for determining membership, there’s no bias that could potentially limit membership. That’s why many financial professionals will turn to the Russell 3000 long before the better-known indices when trying to take the temperature of the market.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

VOIP PAL.COM INC

VOIP-PAL COM Inc is a development stage company. The Company is engaged in broadband Voice-over-Internet Protocol ("VoIP") market with the ownership and continuing development of a portfolio of VoIP Patents.

Private Markets

Pinterest

Pinterest is a visual discovery and planning tool. Users ("Pinners") use the site and apps to get ideas for their future, such as recipes, places to travel, and products to…

MyForce, Inc.

As parents, we constantly worry about the safety of our loved ones. The media bombards us with incidents from across the nation school shootings, frequent assaults on campuses, and crimes…